CorFlow Therapeutics AG develops and validates the CoFl system for diagnosing and treating Microvascular Obstruction (MVO) in heart attack patients.

Broken String Biosciences is a genomics company that develops safer cell and gene therapies by using its INDUCE-seq DNA break mapping technology to measure off-target effects in clinically relevant cells, aiming to enhance the efficiency, safety, and affordability of cell and gene therapies.